R. El Hajj Chehade Et Al. , "Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors," Kidney Cancer Research Summit , Massachusetts, United States Of America, pp.45-46, 2024
El Hajj Chehade, R. Et Al. 2024. Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Kidney Cancer Research Summit , (Massachusetts, United States Of America), 45-46.
El Hajj Chehade, R., Semaan, K., Saliby, R. M., Saad, E., Nawfal, R., Machaalani, M., ... Eid, M.(2024). Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors . Kidney Cancer Research Summit (pp.45-46). Massachusetts, United States Of America
El Hajj Chehade, Razane Et Al. "Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors," Kidney Cancer Research Summit, Massachusetts, United States Of America, 2024
El Hajj Chehade, Razane E. Et Al. "Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors." Kidney Cancer Research Summit , Massachusetts, United States Of America, pp.45-46, 2024
El Hajj Chehade, R. Et Al. (2024) . "Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors." Kidney Cancer Research Summit , Massachusetts, United States Of America, pp.45-46.
@conferencepaper{conferencepaper, author={Razane El Hajj Chehade Et Al. }, title={Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors}, congress name={Kidney Cancer Research Summit}, city={Massachusetts}, country={United States Of America}, year={2024}, pages={45-46} }